Shares in Imricor Medical Systems Inc have been on the slide recently, falling from levels above $2 to just $1.56 at the time of writing. Morgans said in its new research note on the company that its share price had fallen more than 20% since it entered the S&P/ASX 300 Index.
Health
Could this ASX biotech jump more than 80% in value?
Summarized version
Shares in Imricor Medical Systems Inc have been on the slide recently, falling from levels above $2 to just $1.56.
The report’s most important sentence, shortened and in plain words. How
From the report
Headline check
Headline as published: Could this ASX biotech really jump more than 80% in value?
The one thing this headline claims did not turn up in the report.
- The figure “80%” is in the headline. We could not find it in the report.
Figures, names and quoted words in the headline, looked for in the report itself — not in the summary above. Figures are matched digit for digit, so a report that writes “forty per cent” out in words where the headline wrote “40%” is queried here when it should not be. How this is checked
This is a summary. The indicators are not. Every score on this page was measured over the full 442-word report, which is the only way the numbers mean anything.
How this outlet filed it, and how we rewrote it
No other newsroom we read has filed on this event, so there is nothing to compare it with yet.
| Outlet | Niral Score |
|---|---|
| The Motley Fool Australiaas they published this story | 12.9 |
How did this read?
Sign in to react.
Comments
Comments are not open yet. They will be once there is someone to read every one before it appears. If something here is wrong, tell us — that we do read.
Report a problem with these scores or this rewrite — it goes straight into the public ledger.